Literature DB >> 1828823

Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function.

H H Simms1, T A Gaither, L F Fries, M M Frank.   

Abstract

Freshly explanted monocytes phagocytosing IgG antibody-coated erythrocyte targets (EIgG) release a factor(s) that stimulates phagocytosis by neighboring monocytes and polymorphonuclear leukocytes (PMN). Culture supernatants obtained after 30-min incubation of adherent monocytes with EIgG, but not unopsonized sheep erythrocytes, markedly up-regulated the extent of PMN phagocytosis and enhanced the rate at which monocytes ingested EIgG. The presence of this factor(s) was first evident in phagocytic studies in which monocytes were prepared by a colloidal silica-based continuous gradient technique (Sepracell-Mn). After introduction of erythrocyte targets, there was a 20- to 30-min delay before initiation of phagocytosis that was not observed with monocytes prepared by the standard Percoll-gradient technique. Experiments suggest that, when compared with monocytes prepared by the Percoll-gradient method, Sepracell-Mn monocytes are closer to a base line state of activation with regard to the expression of Fc gamma RI and the ability to ingest EIgG. The mechanism of PMN upregulation by the monocyte factor(s) was explored. Monocyte supernatants did not induce an increase in the surface expression of PMN Fc gamma RI, II, or III. Neither anti-TNF, anti-IL-2, nor anti-GM-CSF had any significant effect on monocyte supernatant activity. Neutrophil activating protein-1 was not detected by ELISA. In contrast, anti-IL-1 completely blocked the effect of the supernatant on subsequent monocyte phagocytosis, and partially inhibited its effect on PMN phagocytosis. Furthermore, it was shown that RIL-1 as well as TNF markedly enhanced monocyte and PMN ingestion of EIgG. These results suggest that monocytes, after Fc gamma R-mediated phagocytosis, release monokines, including at least IL-1, which enhance the phagocytic function of neighboring PMN and monocytes to augment the host defense process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Exercising in environmental extremes : a greater threat to immune function?

Authors:  Neil P Walsh; Martin Whitham
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

2.  Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis.

Authors:  P L van Lent; K Nabbe; A B Blom; A E Holthuysen; A Sloetjes; L B van de Putte; S Verbeek; W B van den Berg
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.

Authors:  D R McDonald; M E Bamberger; C K Combs; G E Landreth
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

4.  Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cells.

Authors:  J Davidson; A Kerr; K Guy; D Rotondo
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

5.  Fatal hematophagic histiocytosis after granulocyte-macrophage colony-stimulating factor and chemotherapy for high-grade malignant lymphoma.

Authors:  B Risti; R F Flury; A Schaffner
Journal:  Clin Investig       Date:  1994-06

6.  Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA).

Authors:  A B Blom; P L van Lent ; H van Vuuren ; A E Holthuysen; C Jacobs; L B van de Putte ; J G van de Winkel ; W B van den Berg
Journal:  Arthritis Res       Date:  2000-08-31

Review 7.  The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease.

Authors:  Jessica C Anania; Alicia M Chenoweth; Bruce D Wines; P Mark Hogarth
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

8.  Leukogram Profile and Clinical Status in vivax and falciparum Malaria Patients from Colombia.

Authors:  Alberto Tobón-Castaño; Esteban Mesa-Echeverry; Andrés Felipe Miranda-Arboleda
Journal:  J Trop Med       Date:  2015-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.